Provided by Tiger Trade Technology Pte. Ltd.

Penumbra

325.18
+1.420.44%
Post-market: 325.180.00000.00%16:10 EDT
Volume:167.12K
Turnover:54.34M
Market Cap:12.81B
PE:79.94
High:325.66
Open:323.87
Low:323.87
Close:323.76
52wk High:362.41
52wk Low:221.26
Shares:39.39M
Float Shares:38.19M
Volume Ratio:0.74
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.07
EPS(LYR):4.52
ROE:11.37%
ROA:6.42%
PB:8.37
PE(LYR):71.94

Loading ...

A Look At Penumbra (PEN) Valuation As Trial Hopes Meet A High Earnings Multiple

Simply Wall St.
·
Jun 10

Canaccord Genuity Reaffirms Their Hold Rating on Penumbra (PEN)

TIPRANKS
·
Jun 02

Peninsula Energy Limited's (ASX:PEN) Shift From Loss To Profit

Simply Wall St.
·
May 19

Soros buys Penumbra, exits Take-Two in Q1

TIPRANKS
·
May 16

Penumbra (PEN) Margin Expansion To 11.8% Tests Bulls High P E Narrative

Simply Wall St.
·
May 08

Penumbra is a 'Strong' Strategic fit for Boston Scientific, RBC Says

MT Newswires Live
·
May 08

Penumbra Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
May 07

Penumbra Inc - Stockholders Approve Merger With Boston Scientific - SEC Filing

THOMSON REUTERS
·
May 07

Penumbra shareholders approve merger agreement at special meeting

Reuters
·
May 07

Penumbra price target lowered to $350 from $374 at Citi

TIPRANKS
·
May 07

Penumbra Q1 Adj. EPS $1.00 Misses $1.07 Estimate, Sales $374.758M Beat $371.104M Estimate

Benzinga Earnings
·
May 07

BRIEF-Penumbra Q1 Revenue USD 374.758 Million Vs. IBES Estimate USD 371.1 Million

Reuters
·
May 07

Press Release: Penumbra, Inc. Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Is Penumbra (PEN) Pricing In Too Much Growth After Recent Trial Developments

Simply Wall St.
·
May 03

Boston Scientific Q1 net income climbs 98.8% to $1.34 billion; net sales rise 11.6% to $5.2 billion

Reuters
·
May 01

Penumbra announces annual shareholder meeting

Reuters
·
Apr 30

U.S. Earnings Preview: After Market Close April 29

Dow Jones
·
Apr 30

Boston Scientific cuts 2026 profit forecast, trims revenue growth view

Reuters
·
Apr 22

A Look At Boston Scientific (BSX) Valuation After Recent Share Price Weakness And Penumbra Deal Impact

Simply Wall St.
·
Apr 22

RBC Capital Remains a Hold on Penumbra (PEN)

TIPRANKS
·
Apr 15